Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib

In the past decade, molecular-targeted drugs have been focused upon for the treatment of cancer. In 2002, gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor became available in Japan for the treatment of non-small cell lung cancer (NSCLC). Over 80% of selected patients,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Araki, Takuya, Yashima, Hideaki, Shimizu, Kimihiro, Aomori, Tohru, Hashita, Tadahiro, Kaira, Kyoichi, Nakamura, Tomonori, Yamamoto, Koujirou
Natura: Artigo
Lingua:Inglês
Pubblicazione: Libertas Academica 2012
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520446/
https://ncbi.nlm.nih.gov/pubmed/23239933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S7340
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi